BUILDING THE RATIONALE FOR CLINICAL TRIAL EQUITY ACROSS THE WORLD: THE CASE OF APOL1 NEPHROPATHY IN THE CARIBBEAN

https://storage.unitedwebnetwork.com/files/184/8ce16f7b28f87cca7a6f140c7149d19a.pdf
BUILDING THE RATIONALE FOR CLINICAL TRIAL EQUITY ACROSS THE WORLD: THE CASE OF APOL1 NEPHROPATHY IN THE CARIBBEAN
Lori
Fisher
Shuchi Anand sanand2@stanford.edu Stanford Nephrology Palo Alto
Joseph Myrie myriej01@stanford.edu Stanford University Pediatric Nephrology Palo Alto